Bimode 100mg Injection

Bimode 100mg Injection is an antineoplastic drug belonging to the class of alkylating agents, containing the active ingredient Bendamustine. It is indicated for the treatment of chronic lymphocytic leukaemia (cancer of blood and bone marrow), non-Hodgkin's lymphomas (cancer that forms in the lymph system, part of the immune system), and multiple myelomas (cancer of plasma cells, a type of white blood cell). Common side effects associated with this medicine include headache, insomnia, fatigue, loss of appetite and rashes. Serious side effects may include bone marrow suppression, tumour lysis syndrome, and hepatotoxicity. Inform your healthcare provider if these side effects are of concern or persist for longer than usual. This medicine is often combined with rituximab, an immunotherapy drug, for treatment of various subtypes of non-Hodgkin's lymphoma, including follicular lymphoma and mantle cell lymphoma. There may be an increased risk of certain types of skin cancer (non-melanoma skin cancer) with use of this medicine. Treatment should not be initiated if your white blood cell (leukocyte) counts have fallen below determined levels. Your doctor will assess these values at regular intervals. This medicine should not be used if you are allergic to this drug. Patients who are men and wish to father a child should discuss the treatment with their physician, as this injection may reduce sperm production. Bimode 100mg Injection is typically administered as an intravenous infusion over 30-60 minutes, usually once every three to four weeks. Inform your physician of all medications you have been taking recently, including herbal medicines and supplements, before receiving Bimode 100mg Injection.

Chronic lymphocytic leukaemia. Non-Hodgkin’s lymphomas Multiple myeloma

It is a type of alkylating agent, which works by causing DNA damage and disrupting the cell cycle, leading to cancer cell death. It forms covalent bonds with DNA, inhibits DNA repair enzymes, and blocks cell cycle progression. It is used as a cytotoxic drug that kills cancer cells by inhibiting their DNA and cell cycle.

The medicine will be administered to you by a healthcare professional in a hospital setting. This injection will be given intravenously into a vein in your arm or hand. Do not self-administer this medicine. The dose of the injection will be decided by your doctor based on your disease condition and other factors. This injection is usually given about 30 minutes before you receive your anti-cancer medicine (chemotherapy) or right before anaesthesia for surgery. During the infusion, you will be monitored for any side effects or reactions to the medication. The infusion usually takes several hours to complete, and you may need to receive multiple infusions over the course of several weeks.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Severe allergic reactions Bone marrow suppression Abnormal liver function Tumor lysis syndrome Common Infection, fever Low blood cell count Headache, dizziness Nausea, vomiting Increased blood level of creatinine and urea (chemical waste products) Mucosal inflammation, sore mouth Insomnia, fatigue Hair loss, itching, rash Diarrhea, constipation Missed periods Dehydration, loss of appetite Low or high blood pressure

Bimode 100mg Injection can cause harm to a developing fetus or nursing baby, so it is important to discuss contraception options and the need to avoid breastfeeding during treatment. This drug causes fatigue, so encourage the patient to take enough rest and self-care during treatment. This injection increases the risk of bleeding and bruising, so it is important to be careful when using sharp objects or participating in activities that may result in injury.